Does galactomannan testing increase diagnostic accuracy for IPA in the ICU? A prospective observational study
暂无分享,去创建一个
M. Christner | H. Rohde | D. Wichmann | S. Kluge | V. Fuhrmann | J. Katchanov | A. Laqmani | M. Simon | M. Schroeder | Charles Wijaya
[1] J. Rello,et al. Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes , 2015, Critical Care.
[2] S. Nougaret,et al. Diagnostic yield and safety of CT scans in ICU , 2015, Intensive Care Medicine.
[3] G. Egerer,et al. [Fungal infections in hematology patients and after blood stem cell transplantation: prophylaxis and treatment]. , 2014, Medizinische Klinik, Intensivmedizin und Notfallmedizin.
[4] M. Netea,et al. Voriconazole or Amphotericin B as Primary Therapy Yields Distinct Early Serum Galactomannan Trends Related to Outcomes in Invasive Aspergillosis , 2014, PloS one.
[5] J. Mensa,et al. [Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease]. , 2014, Revista iberoamericana de micologia.
[6] John Moore,et al. Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial. , 2013, The Lancet. Infectious diseases.
[7] A. Solé,et al. Epidemiology, diagnosis and treatment of fungal respiratory infections in the critically ill patient. , 2013, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.
[8] T. Schmitt,et al. Pilzinfektionen bei hämatologischen Patienten und nach Blutstammzelltransplantation , 2013, Medizinische Klinik - Intensivmedizin und Notfallmedizin.
[9] D. Wichmann,et al. Aspergillus Galactomannan Antigen for Diagnosis and Treatment Monitoring in Cerebral Aspergillosis , 2013, Progress in transplantation.
[10] J. Baddley,et al. Aspergillosis in Intensive Care Unit (ICU) patients: epidemiology and economic outcomes , 2013, BMC Infectious Diseases.
[11] P. Olaechea,et al. Epidemiología, diagnóstico y tratamiento de las infecciones fúngicas respiratorias en el paciente crítico , 2013 .
[12] J. Rello,et al. A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. , 2012, American journal of respiratory and critical care medicine.
[13] B. Afessa,et al. Diagnostic criteria for invasive pulmonary aspergillosis in critically ill patients. , 2012, American journal of respiratory and critical care medicine.
[14] Q. Zhan,et al. Role of galactomannan determinations in bronchoalveolar lavage fluid samples from critically ill patients with chronic obstructive pulmonary disease for the diagnosis of invasive pulmonary aspergillosis: a prospective study , 2012, Critical Care.
[15] J. Latgé,et al. Prospective Evaluation of Clinical and Biological Markers To Predict the Outcome of Invasive Pulmonary Aspergillosis in Hematological Patients , 2011, Journal of Clinical Microbiology.
[16] N. Ampel,et al. An official American Thoracic Society statement: Treatment of fungal infections in adult pulmonary and critical care patients. , 2011, American journal of respiratory and critical care medicine.
[17] Patricia Muñoz,et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] A. Wilmer,et al. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. , 2008, American journal of respiratory and critical care medicine.
[19] W. Meersseman,et al. Invasive aspergillosis in the ICU: an emerging disease , 2007, Intensive Care Medicine.
[20] E. van Wijngaerden,et al. Invasive aspergillosis in the intensive care unit. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] J. Ager,et al. Isolation of Aspergillus in critically ill patients: a potential marker of poor outcome. , 2006, Journal of critical care.
[22] S. Blot,et al. Aspergillosis in the ICU - The new 21st century problem? , 2006, Medical mycology.
[23] F. Colardyn,et al. Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients , 2006, Critical care.
[24] A. Wilmer,et al. Invasive aspergillosis in critically ill patients without malignancy. , 2004, American journal of respiratory and critical care medicine.
[25] F. Colardyn,et al. INVASIVE ASPERGILLOSIS IN CRITICALLY ILL PATIENTS: ANALYSIS OF RISK FACTORS FOR ACQUISITION AND MORTALITY , 2004, Acta clinica Belgica.
[26] B. Plikaytis,et al. Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.